DIAGNOSTIC VALUE OF CA-125 IN PATIENTS WITH EPITHELIAL OVARIAN CANCER AT THE DR. SOETOMO GENERAL HOSPITAL SURABAYA IN 2016
DOI:
https://doi.org/10.24293/ijcpml.v25i2.1380Keywords:
Tumor marker CA-125, diagnostic value of CA-125, epithelial ovarian cancerAbstract
Ovarian cancer is the fourth cancer with most incidence in Indonesian female with 10.238 cases in 20141. Tumor marker CA-125 is assosciated with ovarian cancer, importantly epithelial ovarian cancer. This study aims to find out diagnostic value (sensitivity, specificity, positive predictive value, negative predictive value) of CA-125 among patients with epithelial ovarian cancer in Dr. Soetomo General Hospital Surabaya in 2016. This study used analytic cross sectional method and was performed by evaluating medical records of patients suspected for ovarian malignancy in Dr. Soetomo General Hospital Surabaya in 2016. There were total 97 patients found fit for criteria of inclusion in this study. Tissue histopathological examination confirmed 66 patients have epithelial ovarian malignancy and 31 patients do not. Samples distributed using 35 U/ml as CA-125 upper limit, TP: 54.64%, FP: 19.59%, FN: 13.40%, dan TN: 12.37%. Diagnostic value obtained as follows: sensitivity 80.30%, spesificity 38.71%, positive predictive value 73.61%, negative predictive value 48%, and accuracy 67.01%. Tumor marker associated with ovarian cancer CA-125 has found high in sensitivity but low in specificity among patients with epithelial ovarian cancer in Dr. Soetomo General Hospital Surabaya in 2016.
Downloads
References
World Health Organization – Cancer Country Profiles. Indonesia [Internet]. 2014 [cited 2016 July 5]. Available from: http://www.who.int/cancer/country-profiles/idn_en.pdf
National Cancer Institute. SEER Cancer Statistics Factsheets: Ovarian Cancer [Internet]. Bethesda: National Cancer Institute; 2016 [cited 2016 July 5]. Available from: http://seer.cancer.gov/statfacts/html/ovary.html
Sattar, HA. Female Genital System and Breast. In: Kumar, Abbas, Aster, Robbins, editors. Robbins Basic Pathology. 9th ed. Canada: Elsevier. 681-714 pp.
Murdoch JW. Ovarian Surface Epithelium, Ovulation, and Carcinogenesis. Biol. Rev. 1995; 71:529-543.
Ness RB, Grisse JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, Morgan M, Schlesselman JJ. Factors Related to Inflammation of the Ovarian Epithelium and Risk of Ovarian Cancer. Epidemiology [Internet]. 2000 [cited 2017 December 12]; 11(2):111-117. Available from: http://journals.lww.com/epidem/Fulltext/2000/03000/Factors_Related_to_Inflammation_of_the_Ovarian.6.aspx
Ozols RF. American Cancer Society Atlas of Clinical Oncology Ovarian Cancer [Internet]. London: BC Decker; 2003 [cited 2016 July 8]. Available from: https://books.google.co.id/books?id=hCVUNHqd0mcC&printsec=frontcover#v=onepage&q&f=false
Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Gudelines for diagnosis, treatment, and follow-up. Annals of Oncology. 2013; 24(6): vi24-vi25. DOI:10.1093/annonc/mdt333.
Sharma S. Tumor markers in clinical practice: General principles and guidelines. Indian Journal of Medical and Paediatric Oncology [Internet]. 2009 [cited 2017 March 28]; 30(1):1-8. Available from: ncbi.nlm.nih.gov. DOI: http://dx.doi.org/10.4103/0971-5851.56328
Foundation for Women's Cancer. Understanding CA 125 Levels [Internet]. 2011 [cited 2016 July 26]. Available from: http://www.foundationforwomenscancer.org/wp-content/uploads/CA125levels.pdf
ACBI, Duffy MJ, McGing P. Guideline for the use of tumour markers. 2010.
Bon GG, Kenemans P, Verstraeten R, van Kamp GJ, Hilgers J. Serum tumor marker immunoassays in gynecologic oncology: establishment if reference values. Am J Obstet Gynecol. 1996; 174:107-114
Akobeng Anthony K. Understanding diagnostic tests 1: sensitivity, specificity, and predictive values. Acta Paediatrica [Internet]. 2006 [cited 2017 November 12]; 96(3):338-341. Available from: https://umanitoba.ca/faculties/health_sciences/medicine/units/pediatrics/sections/neonatology/media/DiagnosticTest1.pdf. DOI: http://dx.doi.org/10.1111/j.1651-2227.2006.00180.x
Cancer Research UK. Symptoms of Ovarian Cancer [Internet]. 2016 [cited 2017 March 9]. Available from: http://www.cancerresearchuk.org/about-cancer/ovarian-cancer/symptoms
Carnahan, Fedor, Agarwal, dan Gupta. Ovarian endometrioma: guidelines for selection of cases for surgical treatment or expectant management. Expert Review Obsterric Gynecology [Internet]. 2013 [cited 2017 November 19]; 8(1):29-55. Available from: www.expert-reviews.com. DOI: http://dx.doi.org/10.1586/eog.12.75
Mathias Susan D., Kuppermann Miriam, Liberman Rebecca, Lipschutz Ruth C., Steege, John F. Chronic Pelvic Pain: Prevalence, Health-Related, Quality of Life, and Economic Correlates. Obstetrics dan Gynecology [Internet]. 1996 [cited 2017 November 19]; 87(3):321-327. Available from: sciencedirect.com. DOI: http://dx.doi.org/10.1016/0029-7844(95)00458-0
Brown Jubilee and Frumovitz Brown. Mucinous Tumors of the Ovary: Current Thoughts on Diagnosis and Management. Current Oncology Reports [Internet]. 2014 [cited 2017 November 19]; 16(6). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261626/. DOI: http://dx.doi.org/10.1007/s11912-014-0389-x
Wong Hwee Bee and Lim Gek Hsiang. Measures of Diagnostic Accuracy: Sensitivity, Specificity, PPV and NPV. Proceedings of Singapore Healthcare [Internet]. 2011 [cited 2017 November 19]; 20(4):316-318. Available from: http://journals.sagepub.com/doi/pdf/10.1177/201010581102000411. DOI: http://dx.doi.org/10.1177/201010581102000411
Jacobs, I and Bast, RC. The CA-125 tumour associated antigen: a review of the literature. Human Reproduction [Internet]. 1989 [cited 2016 July 27]; 4(1):1-12. Available from: humrep.oxfordjournals.org. DOI: http://dx.doi.org/10.1093/oxfordjournals.humrep.a136832
Murdoch, James William. Ovarian Surface Epithelium, Ovulation, and Carcinogenesis. Biol. Rev. 1995. 71:529-543.
Simundic, Ana-Maria. Measures of Diagnostic Accuracy: Basic Definitions. The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine [Internet]. 2009 [cited 2017 November 20]; 19(4):203-211. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975285/.
